Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan.
Saved in:
| Title: | Safety and Effectiveness of 3 Novel All-Oral Shortened Regimens for Rifampicin- or Multidrug-Resistant Tuberculosis in Kazakhstan. |
|---|---|
| Authors: | Rashitov M; Partners In Health Kazakhstan, Almaty, Kazakhstan., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Trevisi L; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Bekbolatova G; Atyrau Regional Center of Phthisiopulmonology, Atreyu, Kazakhstan., Shalimova J; Karaganda Regional Center of Phthisiopulmonology, Karaganda, Kazakhstan., Eshmetov G; Turkistan Regional Center of Phthisiopulmonology, Turkistan, Kazakhstan., Bektasov S; National Scientific Center of Phthisiopulmonology, Almaty, Kazakhstan., LaHood A; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Arlyapova N; Partners In Health, Boston, Massachusetts, USA., Osso E; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA., Yedilbayev A; World Health Organization, Regional Office for Europe, Copenhagen, Denmark., Korotych O; World Health Organization, Regional Office for Europe, Copenhagen, Denmark., Ciobanu A; World Health Organization, Regional Office for Europe, Copenhagen, Denmark., Skrahina A; The Republican Scientific and Practical Centre for Pulmonology and Tuberculosis, Minsk, Belarus., Mitnick CD; Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Seung KJ; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA., Algozhin Y; Partners In Health Kazakhstan, Almaty, Kazakhstan., Rich ML; Partners In Health, Boston, Massachusetts, USA.; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Oct 15; Vol. 79 (4), pp. 1046-1053. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
